Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
1.17
-
NAV
₹12.15
-
Fund Started
29 Oct 2024
-
Fund Size
₹40.02 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year
12.64%
-
3 Year
-
-
5 Year
-
-
Equity
100.29%
-
Cash
-0.30%
-
Top 10 Holdings
Laurus Labs Ltd. | 9.31% |
Lupin Ltd. | 9.26% |
Fortis Healthcare Ltd. | 7.86% |
Aurobindo Pharma Ltd. | 6.89% |
Glenmark Pharmaceuticals Ltd. | 5.23% |
Alkem Laboratories Ltd. | 5.14% |
Biocon Ltd. | 4.70% |
Mankind Pharma Ltd. | 4.54% |
Ipca Laboratories Ltd. | 3.72% |
Krishna Institute of Medical Sciences Ltd | 3.33% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
-
Launch Date
29 Oct 2024
-
